Literature DB >> 28839565

Diarrhoea in the enterally fed patient.

T E Bowling.   

Abstract

Diarrhoea complicating enteral feeding is very common in all clinical settings. The major risk factor is the use of concomitant antibiotics. The underlying mechanisms for the diarrhoea mainly relate to alterations in the colonic flora and physiological responses to the mode of feed delivery although a clear understanding of what is actually happening in vivo remains elusive. Management of diarrhoea includes rationalising medications, excluding relevant comorbidity and using antidiarrhoeal medications. Altering the method and site of feed delivery-for example, continuous to bolus, gastric to postpyloric-can also be tried in the more difficult cases.

Entities:  

Year:  2010        PMID: 28839565      PMCID: PMC5517180          DOI: 10.1136/fg.2009.000547

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  18 in total

1.  Managing antibiotic associated diarrhoea.

Authors:  Frédéric Barbut; Jean Luc Meynard
Journal:  BMJ       Date:  2002-06-08

Review 2.  Defining and reporting diarrhea in tube-fed patients--what a mess!

Authors:  D Z Bliss; P A Guenter; R G Settle
Journal:  Am J Clin Nutr       Date:  1992-03       Impact factor: 7.045

3.  Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding.

Authors:  D Z Bliss; S Johnson; K Savik; C R Clabots; K Willard; D N Gerding
Journal:  Ann Intern Med       Date:  1998-12-15       Impact factor: 25.391

4.  A valid and reliable tool to quantify stool output in tube-fed patients.

Authors:  P A Guenter; M R Sweed
Journal:  JPEN J Parenter Enteral Nutr       Date:  1998 May-Jun       Impact factor: 4.016

5.  Usefulness of soluble dietary fiber for the treatment of diarrhea during enteral nutrition in elderly patients.

Authors:  Makoto Nakao; Yozo Ogura; Syousuke Satake; Izumi Ito; Akihisa Iguchi; Kenji Takagi; Toshitaka Nabeshima
Journal:  Nutrition       Date:  2002-01       Impact factor: 4.008

6.  Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans.

Authors:  Kevin Whelan; Patricia A Judd; Victor R Preedy; Rainer Simmering; Alfred Jann; Moira A Taylor
Journal:  J Nutr       Date:  2005-08       Impact factor: 4.798

7.  Total artificial nutrition is associated with major changes in the fecal flora.

Authors:  S M Schneider; P Le Gall; F Girard-Pipau; T Piche; A Pompei; J L Nano; X Hébuterne; P Rampal
Journal:  Eur J Nutr       Date:  2000-12       Impact factor: 5.614

8.  Relation between osmolality of diet and gastrointestinal side effects in enteral nutrition.

Authors:  P P Keohane; H Attrill; M Love; P Frost; D B Silk
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-03

9.  Fecal microbiota in patients receiving enteral feeding are highly variable and may be altered in those who develop diarrhea.

Authors:  Kevin Whelan; Patricia A Judd; Kieran M Tuohy; Glenn R Gibson; Victor R Preedy; Moira A Taylor
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

10.  Colonic secretory effect in response to enteral feeding in humans.

Authors:  T E Bowling; A H Raimundo; G K Grimble; D B Silk
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

View more
  3 in total

1.  Diarrhoea in the enterally fed patient: not just a clinical problem.

Authors:  Roland Valori
Journal:  Frontline Gastroenterol       Date:  2010-09-23

2.  Evaluating appropriateness and diagnostic stewardship opportunities of multiplex polymerase chain reaction gastrointestinal testing within a hospital system.

Authors:  Melissa O'Neal; Hanna Murray; Sangita Dash; Majdi N Al-Hasan; Julie Ann Justo; P Brandon Bookstaver
Journal:  Ther Adv Infect Dis       Date:  2020-09-22

3.  Tacrolimus Dose-Conversion Ratios Based on Switching of Formulations for Patients with Solid Organ Transplants.

Authors:  Wen-Yuan Johnson Kuan; Nathalie Châteauvert; Vincent Leclerc; Benoît Drolet
Journal:  Can J Hosp Pharm       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.